483 Kyowa Kirin Pharmaceutical Development Nov 2017

483 Kyowa Kirin Pharmaceutical Development Nov 2017

Nina Yang FDA$119.00 - Available Now

FDA investigators audited the Kyowa Kirin Pharmaceutical Development - Princeton, NJ, United States facility and issued inspectional observations (via FDA 483) on 29 Nov 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Nov 2017
  • Location: Princeton, United States
  • FEI: 3005634747
Add To Cart